A broad spectrum of cardiovascular biomarkers that have been described in patients with DC includes brain natriuretic peptide (BNP), cardiac troponins (T, N, and I), and matrix metalloproteinases (MMPs), particularly MMP-9. The gene discussed is NPPB; the disease is dyskeratosis congenita.